MRSA patients: proven methods to treat colonization and infection

被引:137
作者
Boyce, JM [1 ]
机构
[1] Hosp St Raphael, Div Infect Dis, New Haven, CT 06511 USA
关键词
methicillin-resistant Staphylococcus aureus; nosocomial infections; handwashing; hand hygiene; staphylococcal infections;
D O I
10.1016/S0195-6701(01)90005-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Methicillin-resistant Staphylococcus aureus (MRSA) infections continue to cause serious nosocomial infections in many hospitals. Measures used to control the spread of these infections include ongoing laboratory-based surveillance, placing colonized and infected patients in isolation, use of barrier precautions and handwashing and hand antisepsis. Culturing hospitalized patients at high risk of acquiring MRSA can facilitate detection and isolation of colonized patients. Eradicating MRSA nasal colonization among affected patients and healthcare personnel has also been as a control measure, with variable success. Eradicating MRSA nasal carriage from epidemiologically-implicated healthcare workers has been used on a number of occasions to control outbreaks. Attempts to eradicate MRSA colonization among affected patients has proven difficult. Of more than 40 different decolonization regimens that have been tested during the last 60 years, topical intranasal application of mupirocin ointment has proven to be the most effective. However, intranasal application of mupirocin has limited effectiveness in eradicating colonization in patients who carry the organism at multiple body sites. Furthermore, because decolonization of patients has virtually always been used in combination with other control measures, its efficacy has been difficult to determine. Because MRSA is transmitted primarily on the hands of healthcare workers, greater emphasis should be given to improving hand hygiene practices among health personnel. For patients infected with MRSA, vancomycin remains a drug of choice. (C) 2001 The Hospital Infection Society.
引用
收藏
页码:S9 / S14
页数:6
相关论文
共 39 条
[1]   CONTROL AND ERADICATION OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ON A SURGICAL UNIT [J].
BARTZOKAS, CA ;
PATON, JH ;
GIBSON, MF ;
GRAHAM, R ;
MCLOUGHLIN, GA ;
CROTON, RS .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (22) :1422-1425
[2]   THE INFLUENCE OF CALCIUM MUPIROCIN NASAL OINTMENT ON THE INCIDENCE OF STAPHYLOCOCCUS-AUREUS INFECTIONS IN HEMODIALYSIS-PATIENTS [J].
BOELAERT, JR ;
DESMEDT, RA ;
DEBAERE, YA ;
GODARD, CA ;
MATTHYS, EG ;
SCHURGERS, ML ;
DANEELS, RF ;
GORDTS, BZ ;
VANLANDUYT, HW .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (04) :278-281
[3]  
BOELAERT JR, 1993, NEPHROL DIAL TRANSPL, V8, P235
[4]   SPREAD OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS IN A HOSPITAL AFTER EXPOSURE TO A HEALTH-CARE WORKER WITH CHRONIC SINUSITIS [J].
BOYCE, JM ;
OPAL, SM ;
POTTERBYNOE, G ;
MEDEIROS, AA .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (03) :496-504
[5]   Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus [J].
Caelli, M ;
Porteous, J ;
Carson, CF ;
Heller, R ;
Riley, TV .
JOURNAL OF HOSPITAL INFECTION, 2000, 46 (03) :236-237
[6]   NEW THREATS TO THE CONTROL OF METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS [J].
CASEWELL, MW .
JOURNAL OF HOSPITAL INFECTION, 1995, 30 :465-471
[7]   ELIMINATION OF NASAL CARRIAGE OF STAPHYLOCOCCUS-AUREUS WITH MUPIROCIN (PSEUDOMONIC ACID) - A CONTROLLED TRIAL [J].
CASEWELL, MW ;
HILL, RLR .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 17 (03) :365-372
[8]  
*CDCP, SEM REP 2000
[9]   The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice [J].
Cookson, BD .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) :11-18
[10]   A LABORATORY-CONFIRMED OUTBREAK OF RIFAMPICIN-METHICILLIN RESISTANT STAPHYLOCOCCUS-AUREUS (RMRSA) IN A NEWBORN NURSERY [J].
COOVADIA, YM ;
BHANA, RH ;
JOHNSON, AP ;
HAFFEJEE, I ;
MARPLES, RR .
JOURNAL OF HOSPITAL INFECTION, 1989, 14 (04) :303-312